Ratings

The relationship between the FDA and big pharma has come under scrutiny since Trump nominated RFK to head HHS. The FDA gets half of its income from the pharmaceutical industry through a program called user fees. One of the results is the fact that nine out the past ten FDA commissioners went on to work for big pharma. This is not a surprise to me since I am well aware of how big life insurance companies are in partnership with the rating companies like Moody's and S and P. The insurance companies pay the rating companies for their service. This leads to a conflict of interest.